Drug alert: 18 out of 1571 samples declared as NSQ in March 2021

The manufacturers of these drugs are based in Tamil Nadu, Himachal Pradesh, Madhya Pradesh, Uttarakhand, Telangana, Punjab and Mumbai.

87
Laboratory test chemical
Picture: Pixabay

The Central Drugs Standard Control Organisation (CDSCO) has declared 1,553 as standard quality (SQ) based on testing done on 1,571 samples in the month of March, 2021. However, it concluded that there were only 18 samples which were declared as not of standard quality (NSQ).

The manufacturers of these drugs are based in Tamil Nadu, Himachal Pradesh, Madhya Pradesh, Uttarakhand, Telangana, Punjab and Mumbai.

For detailed NSQ list, click here

Laboratory
Picture: Pixabay

The 18 NSQ drugs include operation theatre gauze (gauze swabs BP 80) manufactured by Anand Product, Tamil Nadu failed the test of (Warp) threads per 10 cm. Surgicom (cotton gauze pad) (absorbent gauze – BP type 13 absorbent cotton wool IP) manufactured by The Ramaraju Surgical Cotton Mills Ltd, Tamil Nadu for failing the test of threads per stated length for the absorbent cotton gauze (13 light). Combine Dressing Pad BP 1980 manufactured by Modern Healthcare, Tamil Nadu which failed the test of sterility. Corsave-10 (rosuvastatin calcium tablets IP 10 mg) manufactured by Synokem Pharmaceuticals Limited, Uttarakhand failed the test of related substances. Xter-250 (terbinafine tablets IP 250 mg) manufactured by Zee Laboratories, Himachal Pradesh and paracetamol tablets IP 650 mg (Febrex -650) manufactured by Indoco Remedies, Mumbai which failed the test of dissolution. Chymocip (trypsin & chymotrypsin tablets) manufactured by Acme Generics LLP, Himachal Pradesh for failing the test of assay of trypsin and chymotrypsin based on analysis done by Central Drugs Laboratory (CDL), Kolkata.


Also read:

Drug alert: 3.52% samples declared NSQ: NIB

Drug alert: 14 out of 1204 samples declared as NSQ in February 2021

Drug alert: 16 out of 1001 samples declared as NSQ in January 2021: CDSCO

15 samples out of 943 declared as NSQ in December: CDSCO

14 samples out of 746 declared as NSQ in Nov 2020: CDSCO


Ondansetron tablets IP 4 mg manufactured by Quest Laboratories, Madhya Pradesh failed the test of dissolution and Moxel-250 (amoxycillin capsules IP 250 mg) manufactured by Venus Biosciences Pvt. Ltd, Himachal Pradesh for failing the test of assay based on analysis done by Central Drugs Testing Laboratory (CDTL), Mumbai.

It also includes Era Care hand sanitizer manufactured by Nature’s Boon Ayurvedic Pharmacy, Punjab which failed the test of identification. Vel-Safe handsanitizer manufactured by Velnex Medicare, Haryana for failing the test of assay of glycerol and hydrogen peroxide. Ofloxacin and ornidazole suspension (intracare RTU suspension) manufactured by Senate Laboratories, Uttarakhand which failed the test of assay of ofloxacin and ornidazole based on analysis done by Regional Drugs Testing Laboratory (RDTL), Chandigarh.

Other drugs include Leegra 120 tablets (fexofenndine hydrochloride tablets IP 120 mg) manufactured by Oaksun Life Sciences, Telangana failed the test of dissolution and Havloc instant hand sanitizer gel manufactured by BRP Industry Pvt. Ltd, Tamil Nadu which failed the test of assay of ethyl alcohol based on analysis done by CDTL, Chennai.


Also read:

Bharat Biotech seeks DCGI’s nod to extend shelf life of Covaxin

IISER develops affordable Oxygen Concentrator

4 arrested for black marketing Remdesivir Injection

Lupin, Sun, Jubilant recall generic medicines in US

Govt exempts customs duty on C-19 vaccine, Oxygen and related equipment

Pharma firms ramp up Remdesivir output


Enter your email address:

Delivered by FeedBurner

Latest updates

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Subscribe here for daily updates
Loading